Found 6 matching trials
A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis
PHASE2The investigators propose to design and conduct a phase IIa clinical trial ...
Location
Universitair Ziekenhuis Antwerpen (UZA)
A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS
PHASE2The investigators propose to design and conduct a phase II clinical trial t...
Location
Antwerp University Hospital
The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells
PHASE1The purpose of this study is to determine the safety and tolerability of th...
Location
Healthcare institution "Minsk City Clinical Endocrinology Center"
A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial
PHASE1A first-in-human clinical trial to treat patients with multiple sclerosis b...
Location
Antwerp University Hospital
Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)
PHASE1The purpose of this study is to determine the safety and tolerability of th...
Location
Hospital Universitari Germans Trias i Pujol
Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA)
PHASE1This is a study which will look at safety, feasibility and acceptability of...
Location
Newcastle University